These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31563221)

  • 1. Surgery in Patients with Portal Hypertension.
    Wong M; Busuttil RW
    Clin Liver Dis; 2019 Nov; 23(4):755-780. PubMed ID: 31563221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome-pathogenesis and treatment.
    Cárdenas A; Arroyo V
    Curr Gastroenterol Rep; 2002 Feb; 4(1):1-4. PubMed ID: 11825535
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver surgery in cirrhosis and portal hypertension.
    Hackl C; Schlitt HJ; Renner P; Lang SA
    World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
    Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review.
    Lahat E; Lim C; Bhangui P; Fuentes L; Osseis M; Moussallem T; Salloum C; Azoulay D
    HPB (Oxford); 2018 Feb; 20(2):101-109. PubMed ID: 29110990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.
    Fares N; Robic MA; Péron JM; Muscari F; Otal P; Suc B; Vinel JP; Bureau C
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):21-26. PubMed ID: 29049129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Developments in Hepatorenal Syndrome.
    Mindikoglu AL; Pappas SC
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison.
    Helton WS; Maves R; Wicks K; Johansen K
    Arch Surg; 2001 Jan; 136(1):17-20. PubMed ID: 11146768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery in patients with portal hypertension: a preoperative checklist and strategies for attenuating risk.
    Im GY; Lubezky N; Facciuto ME; Schiano TD
    Clin Liver Dis; 2014 May; 18(2):477-505. PubMed ID: 24679507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhosis and Portal Hypertension in the Pediatric Population.
    Chapin CA; Bass LM
    Clin Liver Dis; 2018 Nov; 22(4):735-752. PubMed ID: 30266160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension.
    Garcia-Tsao G
    Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.